Cáncer de próstata resistente a la castración metastásico 5 años de experiencia con Acetato de Abiraterona: del ensayo a la práctica clínica - page 13

COU-AA-302: Objetivos primarios/análisis final

RX-PFS

Median follow-up of 49·2 months (IQR 47·0–51·8),

741 (96%) 773 death events

Rathkopf ,

Eur Urol

. 2014

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,3,4,5,6,7,8,9,10,11,12 14,15,16,17,18,19,20,21,22